

Here you will find our lupus forum podcasts recorded by our Steering Committee.
Join Professor Ed Vital and Doctors Reuben Benjamin, Chris Wincup, and Marc Scherlinger on the Lupus Forum in their discussion on the recent webinar “CAR-T and CAR-NK therapies: Are they the future of lupus treatment?” Watch them discuss key highlights from the webinar, including the potential of CAR-T and CAR-NK therapies as transformative treatments for lupus. Highlighting the mechanisms, applications, and the challenges of this treatment. Visit www.lupusforum.com to access the full webinar content, including detailed slide materials from Doctors Reuben Benjamin, Chris Wincup, and Marc Scherlinger.
Join Professors Ed Vital, Cynthia Aranow, Richard Furie, and Chris Edwards as they discuss the role of the JAK-STAT pathway, the emerging evidence of using JAK Inhibitors in clinical trials (SLEek trial), and the need for long-term data and the challenges faced.
Our Steering Committee Member Professor Maria Dall’Era is joined by Professor Vibeke Strand in the latest Lupus Forum podcast. Together they discuss the efficacy of belimumab treatment in patients with SLE. They will also discuss the impact of long-term anifrolumab treatment on patients’ perceived health status and health-related quality of life.
Join Professors Liz Lightstone and Maria Dall’Era for an expert-led discussion focused on lupus nephritis, exploring its current standard of care, practical implementation in clinical settings, and evolving treatment landscape. This podcast will delve into the latest advances in the management of lupus nephritis, including emerging therapies such as obinutuzumab, and examine the future treatment pipeline.
Our Steering Committee Member Professor Chi-Chiu Mok is joined by Professor Chiu Wai Shirley Chan in the latest Lupus Forum podcast. Together they discuss the use of machine learning to identify clusters of SLE patients based on peripheral B cell and plasma cell subsets. They will also discuss the potential predictors of efficacy and safety of belimumab and telitacicept in SLE, and the altering effect of belimumab on autoimmunity in SLE.
Join Professors Ed Vital, Cynthia Aranow, and Richard Furie as they discuss the key takeaways from their recent webinar focusing on the following topics: new and emerging pathways in the treatment of SLE, advances in treatment of SLE, and The challenges confronting SLE clinical trials.